| Literature DB >> 33300311 |
Marcello Ceccaroni1, Giovanni Roviglione2, Mario Malzoni3, Francesco Cosentino3,4, Emanuela Spagnolo5,6, Roberto Clarizia1, Paolo Casadio6, Renato Seracchioli6, Fabio Ghezzi7, Daniele Mautone1, Francesco Bruni1, Stefano Uccella7,8.
Abstract
OBJECTIVE: Total laparoscopic nerve-sparing radical hysterectomy (TL-NSRH) has been considered a promising approach, however, surgical, clinical, oncological and functional outcomes have not been systematically addressed. We present a large retrospective multi-center experience comparing TL-NSRH vs. open abdominal NSRH (OA-NSRH) for early and locally-advanced cervical cancer, with particular emphasis on post-surgical pelvic function.Entities:
Keywords: Cervical Cancer; Hysterectomy; Laparoscopy; Laparotomy; Treatment Outcome
Year: 2020 PMID: 33300311 PMCID: PMC7767655 DOI: 10.3802/jgo.2021.32.e10
Source DB: PubMed Journal: J Gynecol Oncol ISSN: 2005-0380 Impact factor: 4.401
Baseline characteristics of the patients included and peri-operative/histological details
| Characteristic | TL-NSRH (n=170) | OA-NSRH (n=131) | p-value | |
|---|---|---|---|---|
| Age (yr) | 48 (26–78) | 50 (26–79) | 0.259 | |
| BMI (kg/m2) | 22.6 (17.5–40) | 22.9 (17.1–39) | 0.653 | |
| Stage | 0.085 | |||
| IA2 | 34 (20) | 18 (13.7) | ||
| IB1 | 78 (45.9) | 56 (42.7) | ||
| IB2 | 17 (10) | 24 (18.3) | ||
| IIA | 18 (10.6) | 23 (17.6) | ||
| IIB | 17 (10) | 10 (7.6) | ||
| Grading | 0.654 | |||
| 1 | 16 (9.4) | 10 (7.6) | ||
| 2 | 107 (62.9) | 89 (67.9) | ||
| 3 | 47 (27.6) | 32 (24.4) | ||
| Histology | 0.066 | |||
| Squamous | 122 (71.8) | 109 (83.2) | ||
| Adenocarcinoma | 40 (23.5) | 18 (13.7) | ||
| Others | 8 (4.7) | 4 (3.1) | ||
| Lymphovascular space involvement | 42 (24.7) | 29 (22.1) | >0.999 | |
| Neoadjuvant chemotherapy | 51 (30) | 50 (38.2) | 0.137 | |
| Operative time (min) | 208 (95–350) | 220 (100–400) | 0.453 | |
| Blood loss (mL) | 200 (20–1,400) | 400 (50–1,400) | 0.009 | |
| Hospital stay (days) | 3 (2–31) | 5 (4–28) | 0.007 | |
| Pelvic lymphadenectomy | 170 (100) | 131 (100) | >0.999 | |
| No. of pelvic nodes removed | 22 (1–65) | 21 (8–70) | 0.723 | |
| Patients with positive pelvic nodes | 33 (20.9) | 30 (22.9) | 0.476 | |
| Para-aortic lymphadenectomy | 27 (15.9) | 29 (22.1) | 0.179 | |
| No. of para-aortic nodes removed | 18 (4–40) | 13 (1–40) | 0.338 | |
| Patients with positive para-aortic nodes | 9 (5.5) | 10 (7.6) | 0.480 | |
| Adjuvant therapy | 72 (42.4) | 69 (52.6) | 0.076 | |
| Recurrence | 20 (11.8) | 11 (8.4) | 0.341 | |
| Dead of disease | 14 (8.2) | 9 (6.9) | 0.825 | |
Values are presented as median (interquartile range) or number (%).
OA-NSRH, open abdominal; TL-NSRH, total laparoscopic nerve-sparing radical hysterectomy.
Post-operative complications within 7 days
| Type of early post-operative complication (within 7 days) | TL-NSRH (n=170) | OA-NSRH (n=131) | p-value |
|---|---|---|---|
| Hemoperitoneum | 2 (1.2) | 0 | 0.507 |
| Post-operative anemia | 1 (0.6) | 10 (7.6) | 0.014 |
| Urinary retention | 13 (7.6) | 20 (15.2) | 0.041 |
| Urinary incontinence | 1 (0.6) | 1 (0.8) | >0.999 |
| Urinary tract infection | 2 (1.2) | 2 (1.5) | >0.999 |
| Sepsis | 1 (0.6) | 0 | >0.999 |
| Pelvic collection | 1 (0.6) | 0 | >0.999 |
| Dynamic ileum | 0 | 1 (0.8) | 0.435 |
| Pyrexia | 2 (1.2) | 1 (0.8) | >0.999 |
| Bowel subocclusion | 0 | 1 (0.8) | 0.435 |
| Lower limb hyposthenia | 1 (0.6) | 5 (3.8) | 0.089 |
Values are presented as number (%).
OA-NSRH, open abdominal; TL-NSRH, total laparoscopic nerve-sparing radical hysterectomy.
Post-operative complications after >7days
| Type of post-operative complication after >7 days | TL-NSRH (n=170) | OA-NSRH (n=131) | p-value |
|---|---|---|---|
| Dysuria | 5 (2.9) | 7 (5.3) | 0.376 |
| Lymphocele | 10 (5.8) | 15 (11.5) | 0.094 |
| Lymphedema | 10 (5.8) | 8 (6.1) | >0.999 |
| Lymphorrhea | 13 (7.6) | 0 | <0.001 |
| Ureteral fistula | 4 (2.3) | 6 (4.6) | 0.340 |
| Vesico-vaginal fistula | 1 (0.6) | 1 (0.8) | >0.999 |
| Ureteral stenosis | 4 (2.3) | 5 (3.8) | 0.509 |
| Hydronephrosis | 4 (2.3) | 5 (3.8) | 0.509 |
| Thrombophlebitis | 0 | 1 (0.8) | 0.435 |
| Vaginal cuff dehiscence | 4 (2.3) | 0 | 0.135 |
| Abdominal wound dehiscence | 0 | 1 (0.8) | 0.435 |
| Self-catheterization at discharge | 24 (14.1) | 34 (25.9) | 0.012 |
Values are presented as number (%).
OA-NSRH, open abdominal; TL-NSRH, total laparoscopic nerve-sparing radical hysterectomy.
Data regarding urinary and fecal continence and sexual function
| Postoperative elapsed time | Urinary incontinence | p-value | Voiding difficulties | p-value | Anal incontinence | p-value | Fecal constipation | p-value | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TL-NSRH | OA-NSRH | TL-NSRH | OA-NSRH | TL-NSRH | OA-NSRH | TL-NSRH | OA-NSRH | |||||
| Within 1 mo (TL vs. OA 132 vs. 126) | 16 (12.1) | 25 (19.0) | 0.090 | 24 (18.2) | 34 (27.0) | 0.101 | 2 (1.5) | 4 (3.2) | 0.438 | 21 (15.9) | 21 (16.7) | >0.999 |
| 1–6 mo (TL vs. OA 116 vs. 98) | 14 (12.1) | 25 (25.5) | 0.013 | 21 (18.1) | 27 (27.6) | 0.103 | 3 (2.6) | 4 (4.1) | 0.705 | 18 (15.5) | 21 (21.4) | 0.290 |
| 6–12 mo (TL vs. OA 111 vs. 97) | 14 (12.7) | 25 (25.8) | 0.009 | 15 (13.5) | 24 (24.7) | 0.050 | 3 (2.7) | 4 (4.1) | 0.707 | 15 (13.5) | 20 (20.6) | 0.196 |
| 12–24 mo (TL vs. OA 100 vs. 91) | 14 (14.0) | 24 (26.4) | 0.010 | 10 (10.0) | 23 (25.3) | 0.007 | 3 (3.0) | 3 (3.3) | >0.999 | 13 (13.0) | 20 (21.9) | 0.126 |
| >24 mo (TL vs. OA 82 vs. 69) | 11 (13.5) | 22 (31.9) | 0.009 | 3 (3.7) | 18 (26.1) | <0.001 | 3 (3.7) | 3 (4.3) | >0.999 | 8 (9.8) | 17 (24.6) | 0.017 |
Values are presented as number (%).
OA-NSRH, open abdominal; TL-NSRH, total laparoscopic nerve-sparing radical hysterectomy.
Sexual dysfunction after 12 months
| Type of sexual dysfunction | TL-NSRH (n=71) | OA-NSRH (n=65) |
|---|---|---|
| Reduction of frequency of intercourses | 20 (28.2) | 28 (43.1) |
| Dyspareunia | 14 (19.7) | 17 (26.2) |
| Vaginal dryness | 24 (33.8) | 35 (53.8) |
| Use of lubricants | 22 (31.0) | 27 (41.5) |
| Postcoital bleeding | 4 (5.6) | 3 (4.6) |
| Reduced libido | 16 (22.5) | 29 (44.6) |
Values are presented as number (%).
OA-NSRH, open abdominal; TL-NSRH, total laparoscopic nerve-sparing radical hysterectomy.
Fig. 1DFS of the study cohort according to the surgical approach.
DFS, disease-free survival; LPS, laparoscopic surgery; LPT, laparotomy.
Fig. 2OS of the study cohort according to the surgical approach.
LPS, laparoscopic surgery; LPT, laparotomy; OS, overall survival.
Fig. 3DFS in early stage disease.
DFS, disease-free survival; LPS, laparoscopic surgery; LPT, laparotomy.